Key result
The ROBODOC surgical robot system has been used to perform total hip replacement surgery in more than 850 patients across six hospitals worldwide.
Describes the development and initial clinical use of the ROBODOC surgical robot system for total hip replacement.
Robotic hip replacement appears technically feasible; leaves open questions on comparative efficacy and long-term outcomes.
Describes the history of Integrated Surgical Systems (ISS), the US company that created ROBODOC, a surgical robot system used to perform total human hip replacement surgery, and ORTHODOC, a computer workstation that enables orthopaedic surgeons to examine a patient’s bone more accurately and perform a pre‐operative plan prior to total hip replacement (THR) surgery. ISS recently went public on the NASDAQ Small Cap market. ORTHODOC has received US FDA approval, while ROBODOC’s approval is still pending. More than 850 patients in six hospitals worldwide have received surgical procedures performed by ROBODOC.
No takes yet. Share an insight, caveat, or question.
Joanne Pransky (1997) studied Total hip replacement (THR) surgery (n=850). ROBODOC surgical robot system was evaluated. The ROBODOC surgical robot system has been used to perform total hip replacement surgery in more than 850 patients across six hospitals worldwide.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: